Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol—report of three cases

被引：10
作者：
Bohn J.C. [1 ]
Schussel J.L. [1 ,2 ]
Stramandinoli-Zanicotti R.T. [1 ]
Sassi L.M. [1 ]
机构：
[1] Department of Oral and Maxillofacial Surgery, Erasto Gaertner Hospital, Rua Dr. Ovande do Amaral, 201, Curitiba, 81520-060, PR
[2] Graduate Program in Dentistry, Department of Stomatology, Universidade Federal do Paraná, Curitiba, PR
来源：
Oral and Maxillofacial Surgery | 2016年 / 20卷 / 1期
关键词：
Osteoradionecrosis; Pentoxifylline; Radiotherapy; Tocopherol;
D O I：
10.1007/s10006-015-0522-5
中图分类号：
学科分类号：
摘要：
Purpose: Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment. The disease progression can cause important loss on patient’s quality of life after cancer treatment. The options for treatment are limited and include clinical monitoring, prescription, or surgical procedures. As an alternative for bone necrosis treatment, a combination of drugs, pentoxifylline and tocopherol, can be used. Studies have shown that this combination significantly reduces chronic radiotherapy damage. The article reports successful treatment with this prescription protocol. Methods: We report three cases of patients referred to the Service of Oral and Maxillofacial Surgery at Erasto Gaertner Hospital, in Curitiba, Brazil. They were submitted to radiotherapy for the treatment of malignant head and neck tumors and later developed osteoradionecrosis. They were treated with the combination pentoxifylline and tocopherol. Results: All patients achieved complete remission in less than 1 year, with complete healing of bone exposure and without clinical symptoms. Conclusions: This results show that this combination of drugs is beneficial in cases of bone necrosis induced by radiation, avoiding more aggressive treatments and reducing morbidity. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码：97 / 101
页数：4
相关论文
共 31 条
  • [21] Thorn J.J., Hansen H.S., Specht L., Bastholt L., Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation, J Oral Maxillofac Surg, 58, 10, pp. 1088-1093, (2000)
  • [22] Specht L., Oral complications in the head and neck radiation patient. Introduction and scope of the problem, Support Care Cancer, 10, 1, pp. 36-39, (2002)
  • [23] Cheng S.J., Lee J.J., Ting L.L., Tseng I.Y., Chang H.H., Chen H.M., Kuo Y.S., Hahn L.J., Kok S.H., A clinical staging system and treatment guidelines for maxillary osteoradionecrosis in irradiated nasopharyngeal carcinoma patients, Int J Radiat Oncol Biol Phys, 64, 1, pp. 90-97, (2006)
  • [24] Schwartz H.C., Kagan A.R., Osteoradionecrosis of the mandible: scientific basis for clinical staging, Am J Clin Oncol, 25, 2, pp. 168-171, (2002)
  • [25] Mendenhall W.M., Mandibular osteoradionecrosis, J Clin Oncol Off J Am Soc Clin Oncol, 22, 24, pp. 4867-4868, (2004)
  • [26] Rothwell B.R., Prevention and treatment of the orofacial complications of radiotherapy, J Am Dent Assoc, 114, 3, pp. 316-322, (1987)
  • [27] Epstein J.B., Rea G., Wong F.L., Spinelli J., Stevenson-Moore P., Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy, Head Neck Surg, 10, 1, pp. 48-54, (1987)
  • [28] Delanian S., Chatel C., Porcher R., Depondt J., Lefaix J.L., Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial, Int J Radiat Oncol Biol Phys, 80, 3, pp. 832-839, (2011)
  • [29] Williamson R., Kondziolka D., Kanaan H., Lunsford L.D., Flickinger J.C., Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study, Stereotact Funct Neurosurg, 86, 6, pp. 359-366, (2008)
  • [30] Robard L., Louis M.Y., Blanchard D., Babin E., Delanian S., Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results, Eur Ann Otorhinolaryngol Head Neck Dis, 131, 6, pp. 333-338, (2014)
1234